Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Daptomycin-induced eosinophilic pneumonia: a case report and systematic review.
Chemotherapy. 2023 Nov 14. doi: 10.1159/000535190. Online ahead of print.
Chemotherapy. 2023.
PMID: 37963447
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients.
Di Lorenzo A, Tedde S, Pace PG, Campogiani L, Ansaldo L, Lodi A, Zordan M, Barreca F, Caldara F, Rossi B, Imeneo A, Alessio G, Crea AMA, Checchi D, Malagnino V, Teti E, Coppola L, Palmieri R, Buccisano F, Andreoni M, Sarmati L, Iannetta M.
Di Lorenzo A, et al. Among authors: pace pg.
Biomedicines. 2022 Nov 2;10(11):2788. doi: 10.3390/biomedicines10112788.
Biomedicines. 2022.
PMID: 36359306
Free PMC article.
Item in Clipboard
T Lymphocyte Subset Counts and Interferon-Gamma Production in Adults and Children with COVID-19: A Narrative Review.
De Rose DU, Pace PG, Ceccherini-Silberstein F, Dotta A, Andreoni M, Sarmati L, Iannetta M.
De Rose DU, et al. Among authors: pace pg.
J Pers Med. 2023 Apr 28;13(5):755. doi: 10.3390/jpm13050755.
J Pers Med. 2023.
PMID: 37240926
Free PMC article.
Review.
Item in Clipboard
Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience.
Campogiani L, Iannetta M, Di Lorenzo A, Zordan M, Pace PG, Coppola L, Compagno M, Malagnino V, Teti E, Andreoni M, Sarmati L.
Campogiani L, et al. Among authors: pace pg.
Microorganisms. 2023 Jan 25;11(2):312. doi: 10.3390/microorganisms11020312.
Microorganisms. 2023.
PMID: 36838277
Free PMC article.
Item in Clipboard
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study).
Mastrorosa I, Gagliardini R, Segala FV, Mondi A, Lorenzini P, Cerva C, Taddei E, Bai F, Vergori A, Marcantonio N, Pinnetti C, Cicalini S, Murri R, Mazzotta V, Camici M, Mosti S, Bini T, Maffongelli G, Beccacece A, Milozzi E, Iannetta M, Lamonica S, Fusto M, Plazzi MM, Ottou S, Lichtner M, Fantoni M, Andreoni M, Sarmati L, Cauda R, Girardi E, Nicastri E, D'Arminio Monforte A, Palmieri F, Cingolani A, Vaia F, Antinori A; ESCAPE study group.
Mastrorosa I, et al.
EClinicalMedicine. 2023 Mar 10;57:101895. doi: 10.1016/j.eclinm.2023.101895. eCollection 2023 Mar.
EClinicalMedicine. 2023.
PMID: 36936403
Free PMC article.
Item in Clipboard
Cite
Cite